High-risk Human Papillomavirus Testing for Cervical Cancer Screening

被引：2
|
作者：
Totten, Stephanie P. S. [1 ,2 ]
Romero, Joan Miguel [1 ,3 ]
机构：
[1] McGill Univ, Fac Med, Montreal, PQ, Canada
[2] Lady Davis Inst Med Res, Montreal, PQ, Canada
[3] Rosalind & Morris Goodman Canc Res Ctr, 1160 Pine Ave W,Room 611D, Montreal, PQ H3A 1A3, Canada
来源：
JAMA ONCOLOGY | 2021年 / 7卷 / 07期
关键词：
D O I：
10.1001/jamaoncol.2021.0735
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1066 / 1067
页数：9
相关论文
共 50 条
  • [1] High-risk Human Papillomavirus Testing for Cervical Cancer Screening-Reply
    Dang, Le
    Qiao, Youlin
    Lang, Jinghe
    JAMA ONCOLOGY, 2021, 7 (07) : 1067 - 1068
  • [2] Primary High-Risk Human Papillomavirus Testing for Cervical Cancer Screening in the United States Is It Time?
    Flanagan, Melina B.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2018, 142 (06) : 688 - 692
  • [3] Use of Primary High-Risk Human Papillomavirus Testing for Cervical Cancer Screening Interim Clinical Guidance
    Huh, Warner K.
    Ault, Kevin A.
    Chelmow, David
    Davey, Diane D.
    Goulart, Robert A.
    Garcia, Francisco A. R.
    Kinney, Walter K.
    Massad, L. Stewart
    Mayeaux, Edward J.
    Saslow, Debbie
    Schiffman, Mark
    Wentzensen, Nicolas
    Lawson, Herschel W.
    Einstein, Mark H.
    OBSTETRICS AND GYNECOLOGY, 2015, 125 (02): : 330 - 337
  • [4] Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance
    Huh, Warner K.
    Ault, Kevin A.
    Chelmow, David
    Davey, Diane D.
    Goulart, Robert A.
    Garcia, Francisco A. R.
    Kinney, Walter K.
    Massad, L. Stewart
    Mayeaux, Edward J.
    Saslow, Debbie
    Schiffman, Mark
    Wentzensen, Nicolas
    Lawson, Herschel W.
    Einstein, Mark H.
    GYNECOLOGIC ONCOLOGY, 2015, 136 (02) : 178 - 182
  • [5] Use of Primary High-Risk Human Papillomavirus Testing for Cervical Cancer Screening: Interim Clinical Guidance
    Huh, Warner K.
    Ault, Kevin A.
    Chelmow, David
    Davey, Diane D.
    Goulart, Robert A.
    Garcia, Francisco A.
    Kinney, Walter K.
    Massad, L. Stewart
    Mayeaux, Edward J.
    Saslow, Debbie
    Schiffman, Mark
    Wentzensen, Nicolas
    Lawson, Herschel W.
    Einstein, Mark H.
    JOURNAL OF LOWER GENITAL TRACT DISEASE, 2015, 19 (02) : 91 - 96
  • [6] Cost-effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in Quebec, Canada
    Vijayaraghavan, Arthi
    Efrusy, Molly B.
    Mayrand, Marie-Helene
    Santas, Christopher C.
    Goggin, Patricia
    CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 2010, 101 (03): : 220 - 225
  • [7] Cytology and High-Risk Human Papillomavirus Test for Cervical Cancer Screening Assessment
    Stuebs, Frederik A.
    Koch, Martin C.
    Dietl, Anna K.
    Adler, Werner
    Geppert, Carol
    Hartmann, Arndt
    Knoell, Antje
    Beckmann, Matthias W.
    Mehlhorn, Grit
    Schulmeyer, Carla E.
    Gass, Paul
    DIAGNOSTICS, 2022, 12 (07)
  • [8] High-risk human papillomavirus test a good option for cervical cancer screening
    Printz, Carrie
    CANCER, 2018, 124 (24) : 4591 - 4591
  • [9] Urine high-risk human papillomavirus testing - an alternative to routine cervical screening strategy
    Davies-Oliveira, Jennifer C.
    Sargent, Alexandra
    Pinggera, Elisabeth
    Carter, Suzanne
    Gilham, Clare
    Crosbie, Emma J.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 129 : 37 - 37
  • [10] Limitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening
    Naryshkin, Sonya
    Austin, R. Marshall
    DRUG HEALTHCARE AND PATIENT SAFETY, 2013, 5 : 2 - +
12345